Cargando…
Strategy to address innovative off-label medication use in China: grading management
Autores principales: | Wu, Hanbin, Wu, Gao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158171/ https://www.ncbi.nlm.nih.gov/pubmed/25128075 http://dx.doi.org/10.1007/s00228-014-1729-3 |
Ejemplares similares
-
Off-label drugs for obesity
por: Morgan, Andy, et al.
Publicado: (2022) -
Off-label use of rhBMP-2
por: Watts, Clark
Publicado: (2011) -
Anesthesiologist to surgeons’ rescue: An off label use of choledochoscope
por: Aggarwal, Shiba, et al.
Publicado: (2012) -
Less explored off-label indications of dexmedetomidine
por: Nair, Abhijit
Publicado: (2017) -
Off-label Psychotropics Use: Isn’t it Now an Inevitable and a “Norm” in Psychiatry?
por: Khanra, Sourav, et al.
Publicado: (2018)